- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 145.97M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 131.6M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 123.87M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.82M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $52.73M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.62M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $53.36M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $15.11M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $15.58M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $17.91M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.82M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.09M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.91M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.17M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $53.18M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $14.15M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $55.27M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.27M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.63M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.71M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.32M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.86M |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $34K |